-
Aurobindo Pharma bags USFDA nod for Fingolimod Capsules for multiple sclerosis
02 Mar 2024 06:02 GMT
… reference listed drug (RLD), Gilenya Capsules, 0.5 mg of Novartis Pharmaceuticals Corporation … listed drug (RLD), Gilenya Capsules, 0.5 mg of Novartis Pharmaceuticals Corporation … for the treatment of patients with relapsing forms of multiple sclerosis (MS) …
-
Highly Effective Therapies Found Superior to Moderately Effective Therapies as First-Line Treatment in Pediatric MS
06 Mar 2024 23:17 GMT
Onset and diagnosis of multiple sclerosis (MS) typically occur … FDA-approved for use in children with MS are Gilenya … therapies as an index treatment versus using moderately … researchers found that both treatment strategies significantly reduced relapses …
-
The Potential Need for a COVID-19 Vaccine Booster in Multiple Sclerosis
13 Feb 2024 21:46 GMT
… Diseases (NIAID), the trial will include patients with multiple sclerosis (MS), pemphigus, … of our patients with multiple sclerosis, depending on their medication, don't … to the vaccines, are the S1P modulator drugs, which include Gilenya (fingolimod; …
-
Positive Impact of Antiviral Therapy in Multiple Sclerosis
09 Feb 2024 21:51 GMT
… multiple sclerosis (MS) who was also HIV positive showed that treatment … 2015, she began treatment with fingolimod (Gilenya; Novartis). Two years … strong candidate as a drug for primary prevention of … the Department of Clinical Medicine at the University of …
-
Aurobindo Pharma get US FDA approval for Fingolimod Capsules, 0.5 mg
01 Mar 2024 23:03 GMT
… with relapsing forms of multiple sclerosis (MS). The capsules … in such patients.
The medicine manufactured by Aurobindo Pharma … drug (RLD), Gilenya Capsules, 0.5 mg of Novartis Pharmaceuticals … tentative approvals from US FDA.
The Hyderabad-headquartered …
-
A novel molecular link between vitamin B12 and Multiple sclerosis
12 Dec 2023 08:13 GMT
… that resemble those seen in multiple sclerosis (MS). However, the … a medication called FTY720 or fingolimod (brand name Gilenya®) works … vice president of neuroscience drug discovery, said, “The … also extend to novel treatments of other neuroinflammatory and …
-
Unveiling the Link: Vitamin B12 Deficiency and Its Connection to Multiple Sclerosis
12 Dec 2023 12:20 GMT
… that fingolimod, an FDA-approved MS drug, can regulate … system (CNS) – and multiple sclerosis (MS), a chronic disease … also extend to novel treatments of other neuroinflammatory … of Medical Science, Mochida Memorial Foundation for Medical and Pharmaceutical …
-
Astrocyte Study Ties Vitamin B12 to Multiple Sclerosis Progression
11 Dec 2023 23:20 GMT
… drug fingolimod enhances the brain’s B12 uptake, potentially improving MS treatments … fingolimod (Gilenya®), a sphingosine … Medical Science, Mochida Memorial Foundation for Medical and Pharmaceutical … manifestations resembling multiple sclerosis (MS); …
-
Study identifies similarity between deficiency in vitamin B12, multiple sclerosis
11 Dec 2023 20:15 GMT
… as cobalamin) insufficiency and multiple sclerosis.
Researchers at Sanford … of FTY720 or fingolimod (Gilenya®), a sphingosine 1-phosphate … improving drug efficacy for this class of medicines.
The … also extend to novel treatments of other neuroinflammatory …
-
Similarity between vitamin B12 loss and multiple sclerosis revealed
09 Dec 2023 18:04 GMT
… system (CNS) – and multiple sclerosis (MS), a chronic disease … , with the FDA-approved MS drug fingolimod provides a … also extend to novel treatments of other neuroinflammatory … of Medical Science, Mochida Memorial Foundation for Medical and Pharmaceutical …